Table 1.
Symptoms and quality of life in the patient before, during and after Campylobacter infection
|
Questionnaire |
Before infection |
During infection |
After infection |
|||
|---|---|---|---|---|---|---|
| 2 months | 4 months | 6 months | 12 months | |||
| Birmingham |
|
|
|
|
|
|
| Total score |
30 |
35 |
26 |
18 |
29 |
4 |
| Pain |
6 |
15 |
4 |
3 |
6 |
2 |
| Diarrhoea |
4 |
20 |
12 |
8 |
5 |
0 |
| Constipation |
20 |
0 |
10 |
7 |
20 |
2 |
| SF-NDI |
29 |
48 |
20 |
17 |
28 |
13 |
| IBS-QOLa | 61 | 50 | 84 | 86 | 60 | 94 |
Six months after infection, the patient was treated with 2 mg prucalopride daily.
Birmingham, Birmingham Irritable Bowel Syndrome Symptom Questionnaire; SF-NDI, Short-Form Nepean Dyspepsia Index; IBS-QOL, Irritable Bowel Syndrome Quality Of Life Questionnaire.
aPercentage of the total score.